TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance. [electronic resource]
Producer: 20140415Description: 865-74 p. digitalISSN:- 1557-3125
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Astrocytes -- physiology
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cell Survival
- Chickens
- Dacarbazine -- analogs & derivatives
- Drug Resistance, Neoplasm -- genetics
- Epilepsy
- Female
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Glioblastoma -- drug therapy
- Humans
- Mice
- Mice, Nude
- Mice, Transgenic
- NF-kappa B -- antagonists & inhibitors
- Neoplasm Invasiveness -- genetics
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Receptors, Tumor Necrosis Factor -- genetics
- Signal Transduction -- drug effects
- Temozolomide
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.